Kevin has over 25 years of experience in the life science industry, covering a wide range of sectors such as biomanufacturing, biomedical imaging, clinical diagnostics and clinical development. He has been CEO of a number of high growth biotechnology businesses and is currently Chairman of ValiRx PLC, Biorelate Limited and Biotaspheric Limited. 

 

Kevin’s non-business roles have included Board membership of the BIA, Chair of BioNow and membership of various government advisory boards.  He is currently a NED of the British Neuroscience Association and sits on an Industry Advisory Board for UoM.

 

With a passion for improving translational science, Kevin has developed strong links across both public and private sectors and is keen to support the effective application of AI at all stages of drug development to accelerate the availability of new treatments.